Cyclica, a biotech company located in Toronto, is well-known worldwide for its use of artificial intelligence and computational biophysics to transform the process of drug discovery. The company's exclusive AI-enhanced drug exploration platform, which incorporates Ligand Design for multi-targeted and multi-objective drug development, and Ligand Express for off-target analysis, systems biology associations, and structural pharmacogenomic insights, is a testament to their innovation.